Forte Biosciences Inc. (FBRX)
NASDAQ: FBRX
· Real-Time Price · USD
12.02
0.45 (3.89%)
At close: Aug 18, 2025, 3:59 PM
11.80
-1.83%
After-hours: Aug 18, 2025, 06:31 PM EDT
3.89% (1D)
| Bid | 11 |
| Market Cap | 146.81M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -43.71M |
| EPS (ttm) | -9.51 |
| PE Ratio (ttm) | -1.26 |
| Forward PE | -3.18 |
| Analyst | Buy |
| Ask | 13.6 |
| Volume | 129,290 |
| Avg. Volume (20D) | 102,372 |
| Open | 12.13 |
| Previous Close | 11.57 |
| Day's Range | 11.80 - 13.60 |
| 52-Week Range | 4.11 - 28.68 |
| Beta | 2.91 |
About FBRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FBRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FBRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
+2.94%
Forte Biosciences shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
-25.26%
Forte Biosciences shares are trading lower after the company announced the pricing of a $75 million public offering.
1 month ago · businesswire.com
Forte Biosciences Announces Pricing of $75 Million Public OfferingDALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a publ...
